Lactobacillus brevis MAK11L82B and Reduced Allergic Responses

• Effect of orally administered Lactobacillus brevis HY7401 in a food allergy mouse model.

  • 2013-11
  • Clinical Trial
  • Journal of Microbiology and Biotechnology 23(11)
  • • Jeongmin Lee
    • Jieun Bang
    • H. Woo

  • PubMed: 23985541
  • DOI: 10.4014/JMB.1306.06047

  7 Insights on

  • Reduced Allergic Responses

  • Low evidence
  • Animal Study
  • Clinical

  These results reveal that L. brevis HY7401 might be useful to promote anti-allergic processes through oral administration.

  Effect

  Beneficial

  Effect size

  Moderate